MDMA/MDA, Quantitative, Urine
Test Code
17161
80359 (HCPCS: G0480)
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Clinical Significance
MDMA/MDA, Quantitative, Urine - This test is designed to detect the use of the stimulant/ hallucinogen Methylenedioxymethamphetamine (MDMA, XTC, Ecstasy) and its metabolite Methylenedioxyamphetamine (MDA).
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
MDA, MDMA, MDEA
Methodology
Mass Spectrometry (MS)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
| MDA | <200 ng/mL |
| MDMA | <200 ng/mL |
| MDEA | <200 ng/mL |
Alternative Name(s)
EVE, Ecstasy
Minimum Volume
5 mL
Transport Container
Plastic urine container
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 14 days
- Refrigerated: 14 days
- Frozen: 30 days
Reject Criteria
Preserved urine
Setup Schedule, Preferred Specimen(s), Collection Instructions
5 mL
Plastic urine container
Refrigerated (cold packs)
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Preserved urine